Kathryn Hayashi
President and CEO
Kathryn Hayashi is President and CEO of TRIUMF Innovations, the business interface and commercialization arm, connecting TRIUMF, Canada's particle accelerator centre, to the private sector via industry partnerships, licensing, and company creation.
Ms. Hayashi is a Chartered Professional Accountant with more than 25 years of operational and strategic planning, finance and governance experience in not-for-profit organizations, public and private companies, start-ups, and commercialization accelerators/incubators.
Prior to TRIUMF Innovations, she was the Founding Chief Financial Officer of The Centre for Drug Research and Development, Canada’s national drug development and commercialization engine. In addition to her work establishing CDRD as a leader in pre-clinical translational research and commercialization, Ms. Hayashi presides as a Director and Audit Committee Chair of the Center for Commercialization and Cancer Immunotherapy at the Hôpital Maisonneuve-Rosemont, as well as the Discovery Parks technology incubator, and has served on the boards of several spinoff companies.
Keith Ladouceur
Director, Technology Development
Keith Ladouceur is the Director of Technology Development at TRIUMF Innovations where he oversees research and development programs, finds new commercial opportunities for TRIUMF technologies, and provides business development support to TRIUMF researchers.
Keith has held various roles at TRIUMF Innovations, translating his background in science towards business development and creating bridges between academia and industry. He has helped to secure more than $20M in funding for research and commercialization projects and worked on transitioning multiple TRIUMF technologies to successful spin-off companies.
Keith holds a bachelor’s degree in theoretical physics from the University of Guelph and earned a master’s degree in experimental physics from the University of British Columbia.
Michael Trinczek, Ph.D.
Chief Business Operations Officer; Deputy Director, Projects and Infrastructure Division; Manager, Irradiation Facilities - TRIUMF
In his role as Chief Business Operations Officer, Michael Trinczek leads and manages commercial operations and project work as the primary technical and operational liaison that facilitates, enables, and troubleshoots activities that utilize TRIUMF infrastructure and expertise on site. Michael received his PhD in experimental nuclear physics from Simon Fraser University, Canada in 2001 after completing a BSc (Honours) in chemistry. Following a post-doctoral research term at the Max-Planck-Institute for Nuclear Physics in Heidelberg, Germany, he returned to TRIUMF where he has held various roles in facilities and operations. In 2010, Michael assumed responsibility for TRIUMF’s Irradiation Facilities and since then he has been actively involved in the NSREC and RADECS communities where he was part of the research collaboration that won the Outstanding Paper Award at NSREC in 2014 and 2015. He has helped grow the TRIUMF irradiation business over the past few years, using targeted facility upgrades and customer outreach, increasing commercial revenue by more than 400% and regularly hosting many dozens of companies each year. In addition Michael is the scientific secretary for the TRIUMF Life Sciences Projects Evaluation Committee as well as a member of both the IEEE and the Canadian Association of Physicists.